Table 3.
First author, year, reference | Subject | Model | PBM Parameters | Effects |
Victoria E Shaw, 2010[64] | BALB/c albino Mice | Acute MPTP | Transcranial PBM, 1 cm above the head, 670 nm, 40 mw/cm2, 90 s, 10 cm2, 2 J/cm2 | Dopaminergic cells in SNc↑ |
Cassandra Peoples, 2012[65] | BALB/c male mice | Chronic, Acute MPTP | Transcranial PBM, 670 nm, 90 s, 0.5 J/cm2 | Dopaminergic amacrine cells and TH+ cells in retina↑ |
Victoria E Shaw, 2012[66] | BALB/c Mice | Acute, chronic MPTP | Transcranial PBM, 1–2 cm above the head, 670 nm, 90 s, 0.5 J/cm2 | Fos+ cells in subthalamic nucleus and zona incerta ↓ |
Cassandra Peoples, 2012[67] | BALB/c Mice | Chronic MPTP | Transcranial PBM, 1–2 cm above the head, 670 nm, 90 s, 5 J/cm2, 3–5 weeks | TH+ cells in SNc↑ |
Melissa Vos, 2013[68] | Dorsophila | Pink 1 mutants | Transcranial PBM, 808 nm, 25 mw/cm2, 2.5 J/cm2 | Partially rescue the behavioral abnormalities and mitochondrial function of pink1 mutant |
Cecile Moro, 2013[69] | C57BL/6 pigmented mice | Acute MPTP | Transcranial PBM, 1–2 cm above the head, 670 nm, 90 s, 4 times, 2 J/cm2 | TH+ cells ↑ Behavioral impairment ↓ |
Purushothuman S 2013[70] | Mice | K3 (tau transgenic mice) | – | Loss of TH+ cells↓ stress biomarkers: increase of 4-HNE, 8-OHDG, AT-8↓ |
Cecile Moro 2014[71] | BALB/c Mice Sprague-Dawley rats | Acute MPTP | Implanted (lateral ventricles), 0.16 mw, 67 mw | Dopaminergic cells ↑ |
Johnstone DM, 2014[19] | Male BALB/c Mice | MPTP | Remote PBM (applied on the trunk and leg instead of head), 670 nm, 50 mw/cm2, 4 J/cm2 | Damage of TH+ cells in SNc↓ |
Effects of direct transcranial application is better than remote PBM | ||||
Oueslati A, 2015[72] | Sprague-Dawley female Rat | AAV-based α-synuclein overexpression | Transcranial PBM, 808 nm, 2.5–5 mw/cm2, 100 s, once daily for 28 days | Behavioral damage↓ |
Loss of dopaminergic cells↓ | ||||
Florian Reinhart, 2016[73] | Male BALB/c Mice | Acute MPTP | Transcranial PBM, 670 nm, 90 s, twice daily, 1 J/cm2/d | Whether PBM is simultaneously, before or after the MPTP injection, MPTP induced behavioral impairment↓ cell survival ↑ |
Darlot F, 2016[74] | Macaque Monkey | Subacute MPTP | Implanted, 670 nm, 10 mw, 25 J/5 d, 35 J/7 d | Clinical and behavioral impairment↓ |
Dopaminergic cells and their terminations in SN, TH+ cells in stratum↑ | ||||
Nabil El Massri, 2016[75] | Macaque Monkey | Subacute MPTP | Implanted (substantia nigra next to the midline of midbrain) 670 nm, 25/35 J, before injection: NIr delivery (5 s ON/60 s OFF); after injection: 24 h, 10 mw | Astrogliosis in SNc and stratum ↓ |
Florian Reinhart, 2016[76] | Wistar Rat | 6-OHDA | Implanted (Bergma coordinate (–5.6 mm, +2.9 mm, –8.5 mm) 20°), continuous or pulsed, 670 nm, 0.16 mw, twice daily for 23 days, 90 s per time, total dose of 634 mJ | At the stronger power, apomorphine induced rotation↓ |
TH+ cells ↑ | ||||
Nabil El Massri, 2017[77] | Macaque | MPTP | Implanted (midbrain midline), 670 nm, 10 mw | TH+ cells in stratum ↑ |
Monkey | GDNF↑ | |||
Florian Reinhart, 2017[78] | Male BALB/c Mice | MPTP | 670 nm and 810 nm (simultaneously or sequentially) 22 J, 2 days | Motility ↑ |
TH+ cells in SNpc↑ | ||||
Boaz Kim, 2018[20] | Male C57BL/6 mice | MPTP | remote PBM before MPTP injection, 670 nm, 50 mw/cm2, 3 min | Loss of dopaminergic cells↓ |
O’Brien, 2019[79] | Sprague-Dawley Mice (Male) | LPS | Transcranial PBM, 670 nm, 50 mw/cm2, 88 s, twice daily for 6 days | Loss of dopaminergic cells ↓ |
Varshika Ganeshan, 2019[21] | BALB/c mice | MPTP | Remote PBM before MPTP injection, 670 nm, continuous wave, 4 J/cm2, 50 mw/cm2 | Loss of TH+ cells in midbrain ↓ |
increase of FOS+ neurons in putamen and caudate nucleus↓ |
PBM: Photobiomodulation; SNc: Substantia Nigra compacta; SNpc: Substantia Nigra pars compacta; GDNF: Glial cell-derived Neuro trophic factor.